Several ZFPs such as ZNF460, ZNF521, Snail, RNF114, ZEB1, ZNF139, ZFP64, GLIS2, GLI1, ZNF545, ZNF471, RNF180, ZIC1, zFOC1, ZBP89 and RNF43 are ascertained to have potential implications for prognosis prediction in GC and can be possibly used to monitor drug efficacy and the recurrence of GC. This evidence concerns the gene GLIS2 and gastric cancer.